Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Pyrazinamide is a medication used to treat tuberculosis. For active tuberculosis, it is often used with rifampicin, isoniazid, and either streptomycin or ethambutol. It is not generally recommended for the treatment of latent tuberculosis. It is taken by mouth.
The analysis highlights History, Applications and Standards as prominent areas in the source structure around Pyrazinamide.
Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.
Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Explore different angles and find fresh ideas to shape your next piece of content.
Search suggestions related to this topic. Open a question to research it further; suggestions are not verified answers.
Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.
You can skip this section if you’re here for content ideas and keyword inspiration.
The extracted context around Pyrazinamide shows recurring relationship patterns in the source. For example, Pyrazinamide → medication used to treat tuberculosis, most common cause of drug-induced hepatitis, potent antiuricosuric drug and consequently has an off-label use in the diagnosis of causes of hypouricemia and hyperuricosuria Another extracted example is Pyrazinamide → Experiments, Lederle, Merck. Use these groups to spot repeated connection types before inspecting the individual relationships.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
tuberculosis used acid treatment pyrazinoic citation needed resistance pnca liver side effects rifampicin isoniazid rpsa mutations use pyrazinamidase activity also
TTTA extracted 46 structured relationships around Pyrazinamide. Examples in this analysis include Pyrazinamide → 3D model (JSmol) → Interactive image and Pyrazinamide → AHFS/Drugs.com → Monograph. The table shows each extracted connection, where it came from and its confidence.
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Pyrazinamide | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Pyrazinamide | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Pyrazinamide | ATC code | J04AK01 (WHO) J04AM09 (WHO), J04AM10 (WHO), J04AM11 (WHO), J04AM12 (WHO) | 1.00 | infobox |
| Pyrazinamide | Bioavailability | >90% | 1.00 | infobox |
| Pyrazinamide | CAS Number | 98-96-4 Y | 1.00 | infobox |
| Pyrazinamide | ChEBI | CHEBI:45285 Y | 1.00 | infobox |
| Pyrazinamide | ChEMBL | ChEMBL614 Y | 1.00 | infobox |
| Pyrazinamide | ChemSpider | 1017 Y | 1.00 | infobox |
| Pyrazinamide | CompTox Dashboard (EPA) | DTXSID9021215 | 1.00 | infobox |
| Pyrazinamide | DrugBank | DB00339 Y | 1.00 | infobox |
| Pyrazinamide | ECHA InfoCard | 100.002.470 | 1.00 | infobox |
| Pyrazinamide | Elimination half-life | 9 to 10 hours | 1.00 | infobox |
| Pyrazinamide | Excretion | Kidney | 1.00 | infobox |
| Pyrazinamide | Formula | C5H5N3O | 1.00 | infobox |
| Pyrazinamide | IUPHAR/BPS | 7287 | 1.00 | infobox |
| Pyrazinamide | KEGG | D00144 Y | 1.00 | infobox |
| Pyrazinamide | Legal status | US: ℞-only | 1.00 | infobox |
| Pyrazinamide | Legal status | In general: ℞ (Prescription only) | 1.00 | infobox |
| Pyrazinamide | License data | US DailyMed: Pyrazinamide | 1.00 | infobox |
| Pyrazinamide | MedlinePlus | a682402 | 1.00 | infobox |
| Pyrazinamide | Metabolism | Liver | 1.00 | infobox |
| Pyrazinamide | Molar mass | 123.115 g·mol−1 | 1.00 | infobox |
| Pyrazinamide | NIAID ChemDB | 007697 | 1.00 | infobox |
| Pyrazinamide | PubChem CID | 1046 | 1.00 | infobox |
| Pyrazinamide | Routes of administration | By mouth | 1.00 | infobox |
| Pyrazinamide | Trade names | Rifater, Tebrazid, others | 1.00 | infobox |
| Pyrazinamide | UNII | 2KNI5N06TI | 1.00 | infobox |
| Pyrazinamide | is a | medication used to treat tuberculosis | 0.90 | text |
| Pyrazinamide | is a | potent antiuricosuric drug and consequently has an off-label use in the diagnosis of causes of hypouricemia and hyperuricosuria | 0.90 | text |
| Pyrazinamide | is a | most common cause of drug-induced hepatitis | 0.90 | text |
The concept neighborhoods around Pyrazinamide bring nearby vocabulary together. In this analysis, examples include Tuberculosis, Citation and Needed. Use the clusters to find adjacent concepts and terminology that may deserve separate research.
For Pyrazinamide, one of the stronger structural bridges in this analysis connects Pyrazinamide with Overview. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.
TTTA analyzes the structure around Pyrazinamide to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Applications & Standards, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.
Source: Wikipedia — Pyrazinamide · EN edition · Analysis: TopicsToTalkAbout
